SHORTAGES OF PRESCRIPTION MEDICINES
The key objective of the Canadian generic pharmaceutical industry is to provide adequate supply of high quality affordable medicines for Canadian patients through their health care professionals. Any disruption in supply is of serious concern to us.
There have always been issues of drug shortages for both the brand and generic industry. Companies have exacting standards to maintain minimal backlog and excellent inventory fill rates. No one wants to be in any disruptive situation where they cannot supply the market. We understand and sympathize that any disruptions in supply cause significant difficulties for patients, pharmacists, physicians and payers.
CGPA has been very active amongst its own members, with other stakeholders, such as governments, wholesalers and distributors, pharmacists and physicians on lessening the impacts of drug shortages for Canadians. We have developed the CGPA Best Practices for the Prevention, Notification and Management of Drug Shortages for our members to help them ensure the best supply for Canadians.
This website is intended to provide more education and information to readers on the drug shortage issue.
Frequently Asked Questions regarding Drug Shortages